tirzepatide cardiovascular trial An Observational Study of Outcomes of vs Glucagon-Like Peptide-1 Receptor Agonists Tirzepatide and Cardiovascular Outcomes in

Published Oct 1, 2025

Butyrate improved the glucose homeostasis and peripheral insulin-resistance induced by diabetes or HFD without changes in body weight and fat mass (139, 143, 144), which indicates that there are other mechanisms underlying butyrate regulation on glucose homeostasis besides variation in body weight and body composition

Scale Weight vs Fat Loss: Why the Scale Can Be Misleading The number on the scale doesnt tell the whole story

This medicine has caused thyroid tumors in animal studies

& Wu, L.-J

March 19 Product: Takedas Iclusig Indication: Philadelphia chromosome-positive acute lymphoblastic leukemia Takeda scored a frontline approval for its kinase inhibitor Iclusig on Tuesday